Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs

Establishment of functional and stable collaterals in the ischemic myocardium is crucial to restoring cardiac function after myocardial infarction. Here, we show that only dual delivery of a combination of angiogenic and arteriogenic factors to the ischemic myocardium could significantly reestablish...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 104; no. 29; pp. 12140 - 12145
Main Authors Lu, Huixia, Xu, Xinsheng, Zhang, Mei, Cao, Renhai, Bråkenhielm, Ebba, Li, Changjiang, Lin, Huili, Yao, Guihua, Sun, Huiwen, Qi, Lihang, Tang, Mengxiong, Dai, Hongyan, Zhang, Yanen, Su, Runyi, Bi, Yanwen, Zhang, Yun, Cao, Yihai
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 17.07.2007
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Establishment of functional and stable collaterals in the ischemic myocardium is crucial to restoring cardiac function after myocardial infarction. Here, we show that only dual delivery of a combination of angiogenic and arteriogenic factors to the ischemic myocardium could significantly reestablish stable collateral networks and improve myocardial perfusion and function. A combination of FGF-2 with PDGF-BB, two factors primarily targeting endothelial cells and vascular smooth muscle cells, remarkably promotes myocardial collateral growth and stabilizes the newly formed collateral networks, which significantly restore myocardial perfusion and function. Using various members of the PDGF family together with FGF-2 in an angiogenesis assay, we demonstrate that PDGFR-α is mainly involved in angiogenic synergism, whereas PDGFR-β mediates vessel stability signals. Our findings provide conceptual guidelines for the clinical development of proangiogenic/arteriogenic factors for the treatment of ischemic heart disease.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Author contributions: H. Lu, X.X., and M.Z. contributed equally to this work; H. Lu, M.Z., Yun Zhang, and Y.C. designed research; H. Lu, X.X., M.Z., R.C., E.B., C.L., H. Lin, G.Y., H.S., L.Q., M.T., H.D., Yanen Zhang, R.S., and Y.B. performed research; Y.C. contributed new reagents/analytic tools; H. Lu, X.X., and R.C. analyzed data; and H. Lu, X.X., Yun Zhang, and Y.C. wrote the paper.
Communicated by Tadamitsu Kishimoto, Osaka University, Osaka, Japan, May 25, 2007
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0704966104